The prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures

BACKGROUND & AIMS: Programmed death-ligand 1 (PD-L1) has been recognized as a critical and promising target in therapies that direct immune escape of cancers. However, its association with aggressive clinicopathological features in solid tumors remains unclear. We investigated this question by s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ziying, Xu, Yutong, Zhang, Yaxiong, He, Qihua, Zhang, Jianrong, He, Jianxing, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924769/
https://www.ncbi.nlm.nih.gov/pubmed/26930715
http://dx.doi.org/10.18632/oncotarget.7590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924769/
https://www.ncbi.nlm.nih.gov/pubmed/26930715
http://dx.doi.org/10.18632/oncotarget.7590

Ejemplares similares